vs

Side-by-side financial comparison of Aveanna Healthcare Holdings, Inc. (AVAH) and BWX Technologies, Inc. (BWXT). Click either name above to swap in a different company.

BWX Technologies, Inc. is the larger business by last-quarter revenue ($885.8M vs $621.9M, roughly 1.4× Aveanna Healthcare Holdings, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.5% vs 2.3%, a 8.2% gap on every dollar of revenue. On growth, Aveanna Healthcare Holdings, Inc. posted the faster year-over-year revenue change (22.2% vs 18.7%). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (21.1% CAGR vs 14.0%).

Aveanna Healthcare Holdings, Inc. is a leading U.S. provider of home and community-based healthcare services. Its core offerings include pediatric home health, adult personal care, hospice care, and infusion therapy, serving patients across the United States through its nationwide network of local care centers, catering to both public and private payer segments.

BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.

AVAH vs BWXT — Head-to-Head

Bigger by revenue
BWXT
BWXT
1.4× larger
BWXT
$885.8M
$621.9M
AVAH
Growing faster (revenue YoY)
AVAH
AVAH
+3.5% gap
AVAH
22.2%
18.7%
BWXT
Higher net margin
BWXT
BWXT
8.2% more per $
BWXT
10.5%
2.3%
AVAH
Faster 2-yr revenue CAGR
BWXT
BWXT
Annualised
BWXT
21.1%
14.0%
AVAH

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
AVAH
AVAH
BWXT
BWXT
Revenue
$621.9M
$885.8M
Net Profit
$14.1M
$93.0M
Gross Margin
32.6%
Operating Margin
8.6%
10.4%
Net Margin
2.3%
10.5%
Revenue YoY
22.2%
18.7%
Net Profit YoY
132.8%
30.9%
EPS (diluted)
$0.06
$1.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVAH
AVAH
BWXT
BWXT
Q4 25
$885.8M
Q3 25
$621.9M
$866.3M
Q2 25
$589.6M
$764.0M
Q1 25
$559.2M
$682.3M
Q4 24
$519.9M
$746.3M
Q3 24
$509.0M
$672.0M
Q2 24
$505.0M
$681.5M
Q1 24
$490.7M
$604.0M
Net Profit
AVAH
AVAH
BWXT
BWXT
Q4 25
$93.0M
Q3 25
$14.1M
$82.1M
Q2 25
$27.0M
$78.4M
Q1 25
$5.2M
$75.5M
Q4 24
$29.2M
$71.0M
Q3 24
$-42.8M
$69.5M
Q2 24
$13.9M
$73.0M
Q1 24
$-11.2M
$68.5M
Gross Margin
AVAH
AVAH
BWXT
BWXT
Q4 25
Q3 25
32.6%
21.8%
Q2 25
35.8%
25.1%
Q1 25
32.8%
24.2%
Q4 24
33.0%
Q3 24
31.4%
24.4%
Q2 24
31.3%
24.7%
Q1 24
29.7%
24.6%
Operating Margin
AVAH
AVAH
BWXT
BWXT
Q4 25
10.4%
Q3 25
8.6%
13.1%
Q2 25
13.6%
13.4%
Q1 25
9.3%
14.2%
Q4 24
8.8%
12.4%
Q3 24
6.7%
14.4%
Q2 24
7.4%
14.5%
Q1 24
4.7%
15.4%
Net Margin
AVAH
AVAH
BWXT
BWXT
Q4 25
10.5%
Q3 25
2.3%
9.5%
Q2 25
4.6%
10.3%
Q1 25
0.9%
11.1%
Q4 24
5.6%
9.5%
Q3 24
-8.4%
10.3%
Q2 24
2.8%
10.7%
Q1 24
-2.3%
11.3%
EPS (diluted)
AVAH
AVAH
BWXT
BWXT
Q4 25
$1.02
Q3 25
$0.06
$0.89
Q2 25
$0.13
$0.85
Q1 25
$0.03
$0.82
Q4 24
$0.15
$0.77
Q3 24
$-0.22
$0.76
Q2 24
$0.07
$0.79
Q1 24
$-0.06
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVAH
AVAH
BWXT
BWXT
Cash + ST InvestmentsLiquidity on hand
$145.9M
$499.8M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$9.2M
$1.2B
Total Assets
$1.8B
$4.3B
Debt / EquityLower = less leverage
141.83×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVAH
AVAH
BWXT
BWXT
Q4 25
$499.8M
Q3 25
$145.9M
$79.6M
Q2 25
$100.7M
$37.0M
Q1 25
$71.5M
$55.4M
Q4 24
$84.3M
$74.1M
Q3 24
$78.5M
$35.5M
Q2 24
$47.7M
$48.3M
Q1 24
$42.6M
$45.9M
Total Debt
AVAH
AVAH
BWXT
BWXT
Q4 25
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Stockholders' Equity
AVAH
AVAH
BWXT
BWXT
Q4 25
$1.2B
Q3 25
$9.2M
$1.2B
Q2 25
$-12.0M
$1.2B
Q1 25
$-100.1M
$1.1B
Q4 24
$-123.6M
$1.1B
Q3 24
$-156.4M
$1.1B
Q2 24
$-119.0M
$998.5M
Q1 24
$-136.3M
$946.2M
Total Assets
AVAH
AVAH
BWXT
BWXT
Q4 25
$4.3B
Q3 25
$1.8B
$3.8B
Q2 25
$1.8B
$3.7B
Q1 25
$1.7B
$3.1B
Q4 24
$1.7B
$2.9B
Q3 24
$1.6B
$2.9B
Q2 24
$1.7B
$2.8B
Q1 24
$1.6B
$2.8B
Debt / Equity
AVAH
AVAH
BWXT
BWXT
Q4 25
Q3 25
141.83×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVAH
AVAH
BWXT
BWXT
Operating Cash FlowLast quarter
$33.2M
$127.0M
Free Cash FlowOCF − Capex
$56.8M
FCF MarginFCF / Revenue
6.4%
Capex IntensityCapex / Revenue
7.9%
Cash ConversionOCF / Net Profit
2.36×
1.37×
TTM Free Cash FlowTrailing 4 quarters
$295.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVAH
AVAH
BWXT
BWXT
Q4 25
$127.0M
Q3 25
$33.2M
$143.2M
Q2 25
$51.6M
$159.0M
Q1 25
$-8.6M
$50.6M
Q4 24
$13.4M
$276.9M
Q3 24
$29.4M
$32.6M
Q2 24
$1.8M
$65.9M
Q1 24
$-12.0M
$33.0M
Free Cash Flow
AVAH
AVAH
BWXT
BWXT
Q4 25
$56.8M
Q3 25
$94.9M
Q2 25
$126.3M
Q1 25
$17.3M
Q4 24
$224.4M
Q3 24
$-7.7M
Q2 24
$35.5M
Q1 24
$2.6M
FCF Margin
AVAH
AVAH
BWXT
BWXT
Q4 25
6.4%
Q3 25
11.0%
Q2 25
16.5%
Q1 25
2.5%
Q4 24
30.1%
Q3 24
-1.1%
Q2 24
5.2%
Q1 24
0.4%
Capex Intensity
AVAH
AVAH
BWXT
BWXT
Q4 25
7.9%
Q3 25
5.6%
Q2 25
4.3%
Q1 25
4.9%
Q4 24
7.0%
Q3 24
6.0%
Q2 24
4.5%
Q1 24
5.0%
Cash Conversion
AVAH
AVAH
BWXT
BWXT
Q4 25
1.37×
Q3 25
2.36×
1.74×
Q2 25
1.91×
2.03×
Q1 25
-1.66×
0.67×
Q4 24
0.46×
3.90×
Q3 24
0.47×
Q2 24
0.13×
0.90×
Q1 24
0.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVAH
AVAH

Private Duty Services$514.4M83%
Home Health And Hospice$62.4M10%
Medical Solutions$45.1M7%

BWXT
BWXT

Nuclear Component Program$436.4M49%
Nuclear Manufacturing$134.8M15%
Cost Plus Fee$116.1M13%
Uranium And Nuclear Services$103.8M12%
Commercial Operations$49.0M6%
Commercial Operations Segment$33.7M4%
Transferred At Point In Time$1.3M0%

Related Comparisons